stay updated with our newsletter

Today’s Practitioner Congratulates Joshua Mansour, MD in “40 Under 40” Cancer Award

Joshua Mansour

We are honored to congratulate Today’s Practitioner contributor Joshua Mansour, M.D., who was Joshua Mansournamed one of forty of the nation’s most promising young oncology professionals and recognized during the 2nd annual ‘40 Under 40 in Cancer’ awards event June 1 in Chicago, supported by The Lynx Group™, McGivney Global Advisors, Upstream Partners, and Swim Across America. The event celebrates the contributions that individuals under the age of 40 are making to improve the lives of those affected by cancer.

“Early-career leaders in oncology—clinicians, researchers, businesspeople, advocates—are making an enormous impact on patients and the cancer community, but many of these individuals have not had the opportunity to be widely recognized,” said event spokesperson and cancer survivor Jennifer Hinkel. “40 Under 40 in Cancer is an effort to highlight the contributions of these rising stars.”

“These individuals are tomorrow’s driving force in innovation,” added Brian Tyburski, President and CEO, The Lynx Group™. “Their achievements are crucial, well deserved, and should be applauded by all. We’re proud to partner with McGivney Global Advisors, Upstream Partners, and Swim Across America in honoring these 40 individuals for their outstanding achievements and contributions within their respective roles in the cancer continuum.”

Upon receiving the award, Dr. Mansour stated, “I am honored to be included in this esteemed group of people.  Although awards are sometimes presented individually, these accomplishments are rarely, if ever, done alone.  My career thus far has been greatly impacted by several mentors and supporters along the way, in a multitude of different facets of my life.  I would not have received this award without them.  We all as a team, along with countless institutions and organizations around the world, are working as hard as possible to continue to have an impact and improve upon how we treat and care for our patients.”

Nominations came from across the country and represented the following categories:

Clinical and Patient Care Professional

Biopharma, Diagnostics, and Devices

Research, Science, and Technology

Government, Regulatory, and Payer

Patient, Advocacy, and Policy.

Winners of the 2019 “40 Under 40 in Cancer” awards were selected by a panel of judges and include the following:

Amanda Kramar, Association of Community Cancer Centers

Ashley Glode, PharmD, BCOP, University of Colorado–Skaggs School of Pharmacy and Pharmaceutical Sciences

Ashton Gatewood, BSN, RN, CPH, Oklahoma City Indian Clinic

Chelsea Boet, Spectrum Health

Cory Batenchuk, Verily Life Sciences

Dan Fredeman, MEM, Daiichi Sankyo

David Hyman, MD, Memorial Sloan Kettering Cancer Center

Deanna Martinez, Strategix, A Division of The Lynx Group

Gretchen Smythe, Ipsen

Jenna Patel, Regeneron

Jennifer Wong, AstraZeneca

Jeremy Schafer, PharmD, MBA, Precision for Value

Jesse Dresser, Frier Levitt, LLC

Jocelyn Longo, RN, BSN, Ascension Sacred Heart Cancer Center

Joshua Mansour, MD, Stanford University

Justin Birckbichler, Founder, ABSOT (A Ballsy Sense of Tumor)

Kevin Hays, Savarino Companies, LLC

Kip Cross, MBA, Gilead Sciences/Kite

Kristin Marie Ferguson, DNP, RN, OCN, Medstar Georgetown University Hospital

Kyle Smith, Check15

Leticia Iten, MSW, Cancer Resource Center of the Desert

Mackenzi Pergolotti, PhD, OTR/L, Select Medical

Marc Aron Korobkin, JD, Lacuna Loft

Matt Hellmann, Memorial Sloan Kettering Cancer Center

Megan May, PharmD, BCOP, Baptist Health Lexington

Michael Joseph DeLeo III, Southern New Hampshire Health/Foundation Medical Partners

Monica Bryant, Esq, Triage Cancer

Nisha Lakhi, MD, FACOG, Richmond University Medical Center

Quinn Nazarewycz, MSc, QED Therapeutics

Rachel Murphy-Banks, MA, Tufts Medical Center

Raiza Torres, Memorial Cancer Institute

Robert DePriest, Walgreens

Ryan Becerra, The University of Texas at Austin

Scot Niglio, MD, MS, Icahn School of Medicine at Mount Sinai

Scott Huntington, MD, MPH, MSHP, Yale University

Sean Rinella, MPH, University of Wisconsin–Madison

Stephanie A. Fajuri, JD, Cancer Legal Resource Center

Stephen Rosenberg, MD, Moffitt Cancer Center

Tiffany Kendig, PT, DPT, MPH, CLT, Kessler Rehabilitation

Xavier Keutgen, MD, FACS, University of Chicago Medical Center

Dr. Joshua Mansour is a board-certified hematologist/oncologist working and in the field of hematopoietic stem cell transplantation and cellular immunotherapy in Stanford, California. In June 2019 he was a recipient of the ‘40 Under 40 in Cancer’ award. Abstracts, manuscripts, and commentaries by Dr. Mansour have been published in more than 100 esteemed journals and media outlets including US News & World Report, Canada Free Press, Today’s Practitioner, Physician’s News, and KevinMD. He has given countless presentations at conferences and other institutions, and he has helped design and implement clinical studies to evaluate current treatment plans, collaborated on grant proposals and multi-institutional retrospective studies that have been published. Recently Joshua Mansour. M.D. was featured on Fox Television.


Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.